The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

SYMON-II Clinical trials Bluejay is successfully enrolling across all participating sites in its SYMON™ II multicenter IL-6 monitoring study, with a total of 545 patients enrolled with a target of 750 ...

Technology Networks spoke with Dr. Jean-Marc Busnel, principal investigator and senior staff research scientist at Beckman Coulter Life Sciences, to learn about the BAT and how it is being translated ...

However, traditional calorimetric methods typically rely on single-channel measurements, complex fabrication, or long ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

The trial is assessing remibrutinib's safety, tolerability and efficacy in adults with CIndU unresponsive to ...

During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50 years of patient ...

Stage one results from PLL Therapeutics’ first-in-human, multi-stage phase I/II trial show favorable safety and tolerability of PLL001 in 12 ALS patients  Australian multi-stage study tested single ...

Find out how the UK is leading the way in replacing animals in science with strategies that promote non-animal research methods.

Q4 2025 Earnings Call February 17, 2026 8:30 AM ESTCompany ParticipantsKendra Sweeney - Vice President of Investor Relations ...

Enamine's Target-Agnostic Expertise in Biology, Drug Design, and Medicinal Chemistry Advances EMUNO Therapeutics ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...